SCHRODER INVESTMENT MANAGEMENT GROUP – Regeneron Pharmaceuticals, Inc. Transaction History
SCHRODER INVESTMENT MANAGEMENT GROUP portfolio value:
$101.44M
portfolio value
SCHRODER INVESTMENT MANAGEMENT GROUP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +148.80% | 88.07K shares | 66.07M | $688.87 | 147.26K |
Q2 2022 | share | Increase | +18.38% | 9.19K shares | 754K | $591.13 | 59.18K |
Q1 2022 | share | Increase | +73.39% | 21.16K shares | 16.40M | $698.42 | 49.99K |
Q4 2021 | share | Decrease | -36.11% | -16.29K shares | -9.10M | $642.51 | 28.83K |
Q3 2021 | share | Increase | +71.54% | 18.82K shares | 12.62M | $605.18 | 45.13K |
Q2 2021 | share | Increase | +7.18% | 1.76K shares | 3.08M | $558.54 | 26.31K |
Q1 2021 | share | Decrease | -6.31% | -1.65K shares | -1.04M | $473.14 | 24.54K |
Q4 2020 | share | Decrease | -10.14% | -2.95K shares | -3.81M | $483.11 | 26.20K |
Q3 2020 | share | Increase | +98.55% | 14.47K shares | 7.30M | $559.78 | 29.15K |
Q2 2020 | share | Increase | +336.30% | 11.32K shares | 7.46M | $623.65 | 14.68K |
Q1 2020 | share | Increase | +101.20% | 1.69K shares | 1.07M | $488.29 | 3.36K |
Q4 2019 | share | Decrease | -73.12% | -4.55K shares | -1.07M | $375.48 | 1.67K |
Q3 2019 | share | Increase | +673.17% | 5.41K shares | 1.45M | $277.4 | 6.22K |
Q2 2019 | share | 0.00% | 0 shares | -79K | $313 | 805 | |
Q1 2019 | share | Decrease | -2.78% | -23 shares | 22K | $410.62 | 805 |
Q4 2018 | share | 0.00% | 0 shares | -26K | $373.5 | 828 | |
Q3 2018 | share | Decrease | -3.04% | -26 shares | 43K | $404.04 | 828 |
Q2 2018 | share | Decrease | -90.66% | -8.29K shares | -2.85M | $344.99 | 854 |
Q1 2018 | share | Decrease | -30.39% | -3.99K shares | -1.79M | $344.36 | 9.14K |
Q4 2017 | share | Increase | +5.80% | 720 shares | -464K | $375.96 | 13.13K |
Q3 2017 | share | Decrease | -24.63% | -4.05K shares | -2.99M | $447.12 | 12.41K |
Q2 2017 | share | Increase | +49.20% | 5.43K shares | 4.13M | $491.14 | 16.47K |
Q1 2017 | share | Decrease | -19.21% | -2.62K shares | -752K | $387.51 | 11.04K |
Q4 2016 | share | Decrease | -13.42% | -2.11K shares | -1.33M | $367.09 | 13.66K |
Q3 2016 | share | Increase | +1.18% | 184 shares | 898K | $402.02 | 15.78K |
Q2 2016 | share | Decrease | -46.98% | -13.82K shares | -5.13M | $349.23 | 15.60K |
Q1 2016 | share | Increase | +17.66% | 4.41K shares | -2.99M | $360.44 | 29.42K |